Crossmark

Safety and pharmacokinetics of S-1 in a recurrent colon cancer patient with chronic myeloid leukemia treated with dasatinib: a case report

Crossref DOI link: https://doi.org/10.1007/s00280-014-2620-8

Published Online: 2014-11-06

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sueda, Toshinori

Kudo, Toshihiro

Sakai, Daisuke

Uemura, Mamoru

Nishimura, Junichi

Hata, Taishi

Takemasa, Ichiro

Mizushima, Tsunekazu

Yamamoto, Hirofumi

Ezoe, Sachiko

Matsumoto, Kana

Doki, Yuichiro

Mori, Masaki

Satoh, Taroh
License Information

Text and Data Mining valid from 2014-11-06